Clin2
NCT06376396Possibly a fitNot yet recruiting

Two medicines vs one for brain tapeworm infection

Neurocysticercosis

Treatments studied

Part of Brain & nervous system, Infections clinical trials.

This study tests whether giving two medicines (praziquantel and albendazole) together works better than just one medicine (albendazole) to kill the parasite that causes neurocysticercosis. If you have this brain infection and have had seizures, you might be able to participate.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
300 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with active neurocysticercosis (a parasitic infection in the brain) that is causing symptoms like seizures.
  • You are willing to stay in the hospital for about 11–20 days to receive the study treatment.
  • You are willing to have follow-up visits for one year after treatment.
  • You are not pregnant or breastfeeding, and do not have severe health conditions like cancer, HIV/AIDS, or serious allergies to the study drugs.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT00001205Recruiting
Understanding neurocysticercosis outcomes in treated patients

This study follows patients who have been treated for neurocysticercosis—a brain infection caused by a parasite—to learn how they recover over time and what long-term effects they experience. By joining, you'll help doctors better understand this condition and improve care for future patients.

Bethesda, Maryland
NCT07208656Not yet recruiting
Medical TV series to raise awareness about brain tapeworm infection

This study tests whether watching a medical TV drama on Netflix can help young adults learn more about neurocysticercosis, a brain infection caused by a tapeworm. If you are between 18 and 35 and enjoy watching shows, you might help researchers understand how entertainment can improve health knowledge.

NCT06565507Not yet recruiting· Phase 2/Phase 3
Oxfendazole for a single brain cysticercosis lesion

This study tests a medicine called oxfendazole (a type of anti-parasite drug, similar to albendazole) to treat a common form of brain infection caused by a pork tapeworm. If you have just one small lesion from this infection, this treatment may help reduce symptoms and prevent future seizures.

NCT07074444Recruiting
Treating clonorchiasis with three different drugs

This study compares three medicines (albendazole, tribendimidine, and praziquantel) to see which works best for treating clonorchiasis (a liver fluke infection). If you have been diagnosed with this infection, this trial may help find the most effective treatment for you.

Nanning, Guangxi
NCT07262814Recruiting· Phase 2
Testing arpraziquantel for liver fluke in children

This study tests if higher doses of arpraziquantel can safely treat children infected with the liver fluke Opisthorchis viverrini. It aims to find the best dose that clears the infection.

Vientiane
NCT07661316Not yet recruiting· Phase 3
Combination treatments for whipworm infection in schoolchildren

This study tests different combinations of medicines to treat whipworm infection in children. It aims to find the best way to clear the infection and improve children's health.

Tegucigalpa

Hear when a new Neurocysticercosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.